Adequacy of mucosal biopsies for evaluation of intestinal cytokine-specific mRNA

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Digestive Diseases and Sciences

• Publication date

  1995-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF02285198PMID 7543040
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantification of mRNA by polymerase chain reaction (PCR) using an internal standard and a nonradioactive detection method.

  1998cited by this paper
• Cytokines in Inflammatory Bowel Disease

  1996cited by this paper
• Molecular mechanisms of mechanosensation

  1994cited by this paper
• Inflammatory Bowel Disease: From Bench to Bedside

  1994cited by this paper
• Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa.

  1993cited by this paper
• Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells.

  1993cited by this paper
• The role of interleukin-1 in disease.

  1993cited by this paper
• Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice.

  1993cited by this paper
• Immune activation genes in inflammatory bowel disease.

  1993cited by this paper
• Competitive PCR

  1992cited by this paper
• Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis.

  1992influential reference
• Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification.

  1992cited by this paper
• Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease.

  1992cited by this paper
• Soluble interleukin 2 and CD8 and CD4 receptors in inflammatory bowel disease.

  1992cited by this paper
• Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease.

  1992cited by this paper
• The expression and regulation of class II antigens in normal and inflammatory bowel disease peripheral blood monocytes and intestinal epithelium.

  1991cited by this paper
• Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease.

  1991cited by this paper
• Microscopic activity in ulcerative colitis: what does it mean?

  1991cited by this paper
• Tumour necrosis factor‐alpha and interferon‐gamma production measured at the single cell level in normal and inflamed human intestine

  1990cited by this paper
• Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.

  1990cited by this paper
• Plasma and tissue interleukin‐2 receptor levels in inflammatory bowel disease

  1990cited by this paper
• Quantitation of mRNA by the polymerase chain reaction.

  1989cited by this paper
• Pleiotropy and redundancy: T cell-derived lymphokines in the immune response.

  1989cited by this paper
• Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.

  1989cited by this paper
• Interferon γ production by human intestinal mucosal mononuclear cells

  1988cited by this paper
• Expression of HLA-DR antigens in inflammatory bowel disease mucosa: Role of intestinal lamina propria mononuclear cell-derived interferon γ

  1988cited by this paper
• Interleukin-2: inception, impact, and implications.

  1988cited by this paper
• Interferon gamma production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease.

  1988cited by this paper
• Specific DNA amplification

  1988cited by this paper
• Phenotypic analysis of lamina propria lymphocytes

  1986cited by this paper
• Phenotypic analysis of lamina propria lymphocytes. Predominance of helper-inducer and cytolytic T-cell phenotypes and deficiency of suppressor-inducer phenotypes in Crohn's disease and control patients.

  1986cited by this paper
• Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease.

  1984cited by this paper
• Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques.

  1984cited by this paper
• Human intestinal mononuclear cells. I. Investigation of antibody-dependent, lectin-induced, and spontaneous cell-mediated cytotoxic capabilities.

  1980cited by this paper
• Human intestinal mononuclear cells: I. Investigation of antibody-dependent, lectin-induced, and spontaneous cell-mediated cytotoxic capabilities

  1980cited by this paper
• Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization.

  1979cited by this paper
• Gut mucosal lymphocytes in inflammatory bowel disease

  1979cited by this paper

• Expert Recommendations to Standardise Transcriptomic Analysis in Inflammatory Bowel Disease Clinical Trials.

  2025cites this paper
• Density of Biopsy Sampling Required to Ensure Accurate Histological Assessment of Inflammation in Active Ulcerative Colitis.

  2023cites this paper
• Histological Remission in Ulcerative Colitis: Under the Microscope Is the Cure.

  2019cites this paper
• Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol.

  2013cites this paper
• Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?

  2010cites this paper
• Regulatory T cells, Th17 effector cells and cytokine microenvironment in inflammatory bowel disease and coeliac disease.

  2009cites this paper
• An approach to analyze mechanisms of intestinal adaptation following total proctocolectomy

  2006cites this paper
• Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome

  2005cites this paper
• Anti‐Inflammatory Role of Interleukin‐15 in Crohn's Disease

  2005cites this paper
• Suppression of dextran sodium sulfate-induced colitis in mice by zerumbone, a subtropical ginger sesquiterpene, and nimesulide: separately and in combination.

  2003cites this paper
• Over‐expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis

  2003cites this paper
• Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease.

  2002cites this paper
• Mechanisms and modulation of intestinal epithelial repair.

  2001cites this paper
• Influence of glutamine on cytokine production by human gut in vitro.

  2001cites this paper
• Glycine reduces the inflammatory response and organ damage in a two-hit sepsis model in rats.

  2001cites this paper
• Pattern of Cytokine and Adhesion Molecule mRNA in Hapten-Induced Relapsing Colon Inflammation in the Rat

  2001influential citation
• Preventing effect of anti-ICAM-1 and anti-LFA-1 monoclonal antibodies on murine islet allograft rejection

  1999cites this paper
• Endotoxin contamination in isolation of lamina propria mononuclear cells.

  1999cites this paper
• Pathogenesis of Crohn's disease.

  1998cites this paper
• Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation

  1997cites this paper
• Biologic Therapy for Inflammatory Bowel Disease

  1997cites this paper
• Pitfalls in cytokine analysis in inflammatory bowel disease.

  1996cites this paper